Camlin Fine Sciences touches roof on re-commencing trial production at Dahej manufacturing unit

26 Jun 2020 Evaluate

Camlin Fine Sciences is locked at upper circuit limit Rs. 53.35, up by 4.85 points or 10.00% from its previous closing of Rs. 48.50 on the BSE.

The scrip opened at Rs. 53.35 and has touched a high and low of Rs. 53.35 and Rs. 53.00 respectively. So far 15714 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 89.90 on 02-Jan-2020 and a 52 week low of Rs. 33.40 on 25-Mar-2020.

Last one week high and low of the scrip stood at Rs. 53.35 and Rs. 46.05 respectively. The current market cap of the company is Rs. 646.89 crore.

The promoters holding in the company stood at 22.74%, while Institutions and Non-Institutions held 22.27% and 54.99% respectively.

Camlin Fine Sciences has re?commenced trial production at its manufacturing unit located at Dahej on June 25, 2020. The company had shut?down its manufacturing unit at Dahej which was severely affected due to massive explosion in the adjoining unit belonging to Yashashvi Rasayan Private on June 3, 2020. The company was conducting trial production at the said unit.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).


Camlin Fine Sciences Share Price

119.95 0.80 (0.67%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1069.40
SRF 2165.85
Pidilite Inds. 2958.60
Aarti Inds 430.80
Atul 7261.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.